Day: November 24, 2023

Abcourt Announces its Results for the Fourth Quarter and the Year ended June 30, 2023

Abcourt Announces its Results for the Fourth Quarter and the Year ended June 30, 2023

ROUYN-NORANDA, Quebec, Nov. 24, 2023 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) announces that following the management cease trading order (“MCTO”) issued by the Corporation’s principal regulator, the Autorité des marchés financiers (Québec), on November 1, 2023 and the subsequent news release update issued by the Corporation, Abcourt has completed on November 24, 2023 the filing of its audited consolidated financial statements, its management’s discussion and analysis as well as the CEO and CFO certificates for the year ended June 30, 2023 (collectively, the “Annual Filings”) under its SEDAR+ profile at www.sedarplus.ca and on its website. Consequently, the Corporation expects the MCTO to be revoked by securities regulators in accordance with Policy Statement 12-203 respecting Management...

Continue reading

Etrion Releases Third Quarter 2023 Results

Etrion Releases Third Quarter 2023 Results

GENEVA, Switzerland, Nov. 24, 2023 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2023. Q3-23 HIGHLIGHTS Etrion closed the third quarter of 2023 with an unrestricted cash balance of US$11.2 million and a positive working capital of US$8.5 million. The Company sold all the solar assets in 2021 and is not developing any new project in 2023. The Company will complete its windup activities and proceed with the dissolution of all the Company’s legal entities. Any cash remaining at the completion of the windup activities and settlement of all liabilities of the Company will be distributed...

Continue reading

Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 9 months of 2023 (unaudited)

Silvano Fashion Group Consolidated Interim Financial Report for Q3 and 9 months of 2023 (unaudited)

Selected Financial Indicators Summarized selected financial indicators of the Group for 9 months of 2023 compared to 9 months of 2022 and 30.09.2023 compared to 31.12.2022 were as follows: in thousands of EUR 09m 2023 09m 2022 Change Revenue 46 739 43 974 6.3% Gross Profit 28 078 22 066 27.2% Operating profit 16 267 10 611 53.3% EBITDA 18 630 13 180 41.4% Net profit for the period 8 842 12 516 -29.4% Net profit attributable equity holders of the Parent company 7 912 11 835 -33.1% Earnings per share (EUR) 0,22 0,33 -33.3% Operating cash flow for the period 15 369 12 493 23.0%         in thousands of EUR 30.09.2023 31.12.2022 Change Total assets 68 338 63 991 6.8% Total current assets 56 832 50 309 13.0% Total...

Continue reading

Traction Uranium Announces Closing of the Second Tranche of Private Placement

Traction Uranium Announces Closing of the Second Tranche of Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 24, 2023 (GLOBE NEWSWIRE) — Traction Uranium Corp. (CSE: TRAC) (OTCQB: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce that, further to its news release of October 27, 2023 and November 14, 2023 which announced: i.) a private placement offering (the “Offering”) of up to 10,000,000 non-flow through units (“NFT”) and up to 5,714,285 flow-through (“FT”) units, as well as, ii.) the closing of the first tranche of the Offering, respectively, it has closed the second tranche of the Offering (the “Second Tranche”) by issuing 2,000,000 FT units (each, an “FT Unit”) at a price of $0.175 per FT Unit, for aggregate gross proceeds of $350,000. Each FT Unit consisted of one (1) “flow-through”...

Continue reading

Orezone Files Bomboré Phase II Expansion Study Technical Report

Orezone Files Bomboré Phase II Expansion Study Technical Report

VANCOUVER, British Columbia, Nov. 24, 2023 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) announces that, further to its news release dated October 11, 2023, the Company has filed an independent National Instrument 43-101 technical report entitled “Bomboré Phase II Expansion, Definitive Feasibility Study” (the “FS”). A copy of the FS is available on SEDAR+ and the Company’s website. The FS was prepared for Orezone by personnel from Lycopodium Mineral Canada Ltd. and other industry consultants, each of whom is a “qualified person” within the meaning of NI 43-101 and considered to be “independent” of the Company under Section 1.5 of NI 43-101. About Orezone Gold Corporation Orezone Gold Corporation (TSX: ORE OTCQX: ORZCF) is a Canadian mining company operating...

Continue reading

VILNIAUS BALDAI AB annual audited information for the year 2023

VILNIAUS BALDAI AB annual audited information for the year 2023

Please find attached VILNIAUS BALDAI AB audited consolidated and company’s financial statements for the year 2023 ended 31 August 2023 with independent auditor’s report. Enclosed: Independent auditor’s report, consolidated annual report, consolidated and company’s financial statements for the year 2023 ended 31 August 2023. Additional information: General manager Jonas Krutinis Phone No: +370 5 2525700 Attachments abvilniausbaldai-2023-08-31-en CONSOLIDATED AND COMPANY’S FINANCIAL STATEMENTS FOR THE FY 2023 ENDED 31 AUGUST 2023

Continue reading

HPQ Silicon Inc.: Final Closing of Financing

HPQ Silicon Inc.: Final Closing of Financing

MONTREAL, Nov. 24, 2023 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering processes for silica and silicon material production is pleased to inform shareholders that it closed the its Non-Brokered Private placement financing announced on October 16, 2023. In addition to the 1,225,500 units as announced on November 16, 2023, the company announces the closing of additional 981,818 units at a price of $ 0.275 per unit for a gross proceed of $ 269,999.94, bringing the total amount raised at $ 607,012.44 and the total number of units issued at 2,207,318. “Successfully raising more than $ 600,000 at a premium of almost 9% to market, in these less-than-ideal market conditions, is another demonstration of the interest in the HPQ value...

Continue reading

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing

FLORHAM PARK, N.J., Nov. 24, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (the “Company”), a biotechnology company developing allogeneic cell therapies and biomaterial products, announced today that on November 21, 2023, the Company received notification from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq’s continued listing requirements of the Company’s failure to timely file a Form 10-Q for the third quarter of 2023. The Company is required to submit to Nasdaq a plan to regain compliance within 60 calendar days, or by January 22, 2024, and if accepted, the Company has a period of 180 calendar days from the Q3 2023 Form 10-Q due date, or until May 20, 2024, to implement the plan to regain compliance. The Company intends to submit...

Continue reading

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

Gain Therapeutics Announces Closing of $10.1 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants, Including Full Exercise of Over-Allotment Option

BETHESDA, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the closing of an underwritten public offering of 2,545,000 shares of its common stock and warrants to purchase up to an aggregate of 1,272,500 shares of its common stock at a combined public offering price of $2.005 per share and accompanying warrant, including 331,956 shares of common stock and warrants to purchase 165,978 shares of common stock issued pursuant to the full exercise by the underwriter of its over-allotment option. The public offering price for each set of two shares of common stock and accompanying warrant to purchase one share of common stock was $4.01 per set of securities, yielding an effective price of $2.00 per share and $0.01 per warrant. The warrants were sold at the rate of one...

Continue reading

Innofactor Plc: Share Repurchase 24.11.2023

Innofactor Plc: Share Repurchase 24.11.2023

Innofactor Plc Announcement 24.11.2023             Innofactor Plc: Share Repurchase 24.11.2023         In the Helsinki Stock Exchange           Trade date 24.11.2023   Bourse trade Buy   Share IFA1V   Amount 4,600 Shares Average price/ share 1.1349 EUR Total cost 5,220.54 EUR             Innofactor Plc now holds a total of 538 529 shares including the shares repurchased on 24.11.2023             On behalf of Innofactor Plc           Nordea Bank Oyj           Janne Sarvikivi Sami Huttunen         Additional information:     Sami Ensio, CEO     Innofactor Plc     Tel. +358 50 584 2029     sami.ensio@innofactor.com           www.innofactor.com         Attachment Innofactor_24.11_trades

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.